ResearcherCatholic University of KoreaActive in the last 2 years
Eun Sun Jung
Matched on ORCID iD 0000-0002-8451-939X; OpenAlex author ID A5103043413. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 4
- Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing. Co-author DOI 10.3389/fonc.2024.1304187↗
- Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. Last author DOI 10.3390/biomedicines10061289↗
- Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography. Last author DOI 10.1371/journal.pone.0240318↗
- Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III? Co-author DOI 10.1016/j.ejca.2018.08.027↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Moon Hyung Choi · 4 shared papers, 2018–2024 · strength 0.61
- Paper Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and ne… DOI 10.3389/fonc.2024.1304187↗
- Paper Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. DOI 10.3390/biomedicines10061289↗
- Paper Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography. DOI 10.1371/journal.pone.0240318↗
- Seung Bae Yoon · 4 shared papers, 2018–2024 · strength 0.61
- Paper Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and ne… DOI 10.3389/fonc.2024.1304187↗
- Paper Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. DOI 10.3390/biomedicines10061289↗
- Paper Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography. DOI 10.1371/journal.pone.0240318↗
- In Seok Lee · 3 shared papers, 2018–2022 · strength 0.37
- Paper Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. DOI 10.3390/biomedicines10061289↗
- Paper Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography. DOI 10.1371/journal.pone.0240318↗
- Paper Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcino… DOI 10.1016/j.ejca.2018.08.027↗
- Myung Ah Lee · 3 shared papers, 2018–2022 · strength 0.37
- Paper Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. DOI 10.3390/biomedicines10061289↗
- Paper Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography. DOI 10.1371/journal.pone.0240318↗
- Paper Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcino… DOI 10.1016/j.ejca.2018.08.027↗
- Tae Ho Hong · 3 shared papers, 2018–2022 · strength 0.37
- Paper Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. DOI 10.3390/biomedicines10061289↗
- Paper Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography. DOI 10.1371/journal.pone.0240318↗
- Paper Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcino… DOI 10.1016/j.ejca.2018.08.027↗
- Ho Joong Choi · 2 shared papers, 2018–2022 · strength 0.25
- Dongyeob Han · 1 shared paper, 2024 · strength 0.24
- Dominik Marcel Nickel · 1 shared paper, 2024 · strength 0.24
- Meiying Song · 2 shared papers, 2018–2020 · strength 0.21
- Young Hoon Choi · 1 shared paper, 2022 · strength 0.16
- Myung‐Gyu Choi · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.